Published in Lancet on June 06, 2005
Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis (2009) 2.38
Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prev Res (Phila) (2014) 2.20
Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci (2010) 2.03
Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Environ Health Perspect (2006) 1.89
A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer (2011) 1.54
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
Environmental exposure measurement in cancer epidemiology. Mutagenesis (2008) 1.19
Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncol Lett (2013) 1.08
Health economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventions. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2010) 1.07
Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment. World J Hepatol (2012) 1.01
Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2010) 0.98
Association between anemia and aflatoxin B1 biomarker levels among pregnant women in Kumasi, Ghana. Am J Trop Med Hyg (2010) 0.96
Human aflatoxin exposure in Kenya, 2007: a cross-sectional study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2013) 0.95
Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B(1) in rats. Appl Environ Microbiol (2006) 0.92
Problem of hepatocellular carcinoma in West Africa. World J Hepatol (2014) 0.86
Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 Cells. Appl Environ Microbiol (2007) 0.86
Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin B₁-lysine albumin biomarkers. Food Chem Toxicol (2014) 0.83
Global risk assessment of aflatoxins in maize and peanuts: are regulatory standards adequately protective? Toxicol Sci (2013) 0.83
Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol (2010) 0.82
Dietary exposure to aflatoxin and fumonisin among Tanzanian children as determined using biomarkers of exposure. Mol Nutr Food Res (2013) 0.81
Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2010) 0.81
The molecular epidemiology of chronic aflatoxin driven impaired child growth. Scientifica (Cairo) (2013) 0.80
Perspective: time to face the fungal threat. Nature (2014) 0.80
An overview on mycotoxin contamination of foods in Africa. J Vet Med Sci (2014) 0.78
Reducing Postharvest Losses during Storage of Grain Crops to Strengthen Food Security in Developing Countries. Foods (2017) 0.75
Prevention of Hepatocellular Carcinoma. Gastrointest Tumors (2016) 0.75
Dietary exposure to aflatoxin and micronutrient status among young children from Guinea. Mol Nutr Food Res (2015) 0.75
Chronic aflatoxin exposure in children living in Bhaktapur, Nepal: Extension of the MAL-ED study. J Expo Sci Environ Epidemiol (2016) 0.75
Occurrence of aflatoxins and its management in diverse cropping systems of central Tanzania. Mycotoxin Res (2017) 0.75
Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ (1990) 10.85
The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet (1991) 6.00
Follow up study of children born to mothers resident in Seascale, West Cumbria (birth cohort). Br Med J (Clin Res Ed) (1987) 5.42
Follow up study of children born elsewhere but attending schools in Seascale, West Cumbria (schools cohort). Br Med J (Clin Res Ed) (1987) 4.38
Measles and atopy in Guinea-Bissau. Lancet (1996) 4.03
Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax (2005) 3.81
The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol (1994) 3.23
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74
Methods and basic data of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ (1990) 2.70
The emergence of life from iron monosulphide bubbles at a submarine hydrothermal redox and pH front. J Geol Soc London (1997) 2.46
Risk factors for transmission of hepatitis B virus to Gambian children. Lancet (1990) 2.35
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst (2000) 2.24
Do bedbugs transmit hepatitis B? Lancet (1994) 2.17
Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question. BMJ (2001) 2.15
The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci (1993) 2.12
Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res (2000) 2.09
What level of hepatitis B antibody is protective? J Infect Dis (1999) 2.02
Risk factors for mortality from acute lower respiratory tract infections in young Gambian children. Int J Epidemiol (1993) 1.99
Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ (2002) 1.96
Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis (2006) 1.91
Hepatitis B vaccination: protection for how long and against what? BMJ (1993) 1.90
Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst (1997) 1.86
Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine (1999) 1.65
A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol (2005) 1.63
Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Int Health (2000) 1.60
Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer (1991) 1.55
Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res (1988) 1.54
A British Medical Association Lecture on Post-Encephalitic Parkinsonism. Br Med J (1926) 1.52
Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet (2003) 1.48
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet (1991) 1.46
Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J (2005) 1.46
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol (1998) 1.44
Pyogenic infections occurring primarily in intervertebral discs. J Bone Joint Surg Br (1973) 1.44
Aflatoxin biomarkers. Lancet (1992) 1.42
Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect (1996) 1.42
Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A (1995) 1.41
Eradication or control? Trop Med Int Health (1997) 1.40
Diffuse Neurofibromatosis. Proc R Soc Med (1912) 1.40
Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci U S A (2001) 1.39
Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis (2006) 1.38
Cancer in the Gambia: 1988-97. Br J Cancer (2001) 1.38
Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy (2000) 1.37
Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning. Int J Epidemiol (2003) 1.37
Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis? Epidemiology (1997) 1.32
p53 antibodies in patients with various types of cancer: assay, identification, and characterization. Clin Cancer Res (1995) 1.31
The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis (1990) 1.31
Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang (2003) 1.30
Serpentinization as a source of energy at the origin of life. Geobiology (2010) 1.29
Domestic pets as risk factors for alveolar hydatid disease in Austria. Am J Epidemiol (1998) 1.26
Bacteriological sampling of postmortem rooms. J Clin Pathol (1989) 1.24
Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology (2002) 1.24
Environmental risk factors for clinical malaria: a case-control study in the Grau region of Peru. Trans R Soc Trop Med Hyg (2002) 1.23
Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru. Trop Med Int Health (2002) 1.22
Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia. Int J Cancer (2000) 1.22
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.21
Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology (1999) 1.21
The pattern of infant and childhood mortality in Upper River Division, The Gambia. Ann Trop Paediatr (1993) 1.21
A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health (2001) 1.20
Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation? Vaccine (1999) 1.18
Epidemiology of hepatitis B virus infection in the Middle East. East Mediterr Health J (2001) 1.18
O(6)-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer (1985) 1.17
Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye (Lond) (2003) 1.17
Evaluation of the Singh index and femoral calcar width as epidemiological methods for measuring bone mass in the femoral neck. Clin Radiol (1986) 1.16
Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopy. Gut (2007) 1.16
Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet (1993) 1.15
Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis (1990) 1.15
Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales. J Epidemiol Community Health (1995) 1.15
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hyg (1992) 1.15
Optical disk archiving using a personal computer: a solution to image storage problems in diagnostic imaging departments. J Med Eng Technol (1990) 1.14
Ultrasound and chromosome damage. Br J Radiol (1972) 1.14
Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992-1995. Int J Cancer (1997) 1.14
Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis (1986) 1.14
The first 2 years of the Gambian National Cancer Registry. Br J Cancer (1990) 1.14
The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis (1992) 1.13
Nd:YAG laser iridotomy in uveitic glaucoma. Clin Experiment Ophthalmol (2001) 1.12
Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol (2003) 1.12
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. J Viral Hepat (2009) 1.10
Mothers, malaria and resistance. Trop Med Int Health (2000) 1.10
Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.09
The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia. Chest (1999) 1.09
Diagnosis of pneumococcal pneumonia in epidemiological studies: evaluation in Kenyan adults of a serotype-specific urine latex agglutination assay. Clin Infect Dis (1999) 1.08
Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children. Cancer Epidemiol Biomarkers Prev (1994) 1.08
Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin Infect Dis (1998) 1.07
Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus. Am J Pathol (1997) 1.06
Symptoms in relation to chemicals and dampness in newly built dwellings. Int Arch Occup Environ Health (2004) 1.04
Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J (2000) 1.04
TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort. Gut (2006) 1.03
Changing causes of death in the West African town of Banjul, 1942-97. Bull World Health Organ (2001) 1.02
Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis (1992) 1.02